XML 33 R27.htm IDEA: XBRL DOCUMENT v3.26.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity

A summary of iMDx’s 2010 Plan and 2018 Incentive Plan activity and related information follows:

 

 

Options

 

 

Nonvested RSUs

 

 

Number
Outstanding

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Life

 

Aggregate
Intrinsic
Value

 

 

Number
Outstanding

 

 

Weighted
Average
Grant
Date Fair
Value

 

 

(In thousands, except weighted average amounts)

 

Balance at December 31, 2025

 

 

2,251

 

 

$

7.11

 

 

8.92 years

 

$

8,537

 

 

 

852

 

 

$

3.03

 

Awards granted

 

 

 

 

$

 

 

 

 

 

 

 

 

 

 

$

 

Options exercised

 

 

 

 

$

 

 

 

 

$

 

 

n/a

 

 

n/a

 

RSUs vested

 

n/a

 

 

n/a

 

 

 

 

 

 

 

 

(168

)

 

$

3.18

 

Options forfeited/expired

 

 

(2

)

 

$

61.20

 

 

 

 

 

 

 

n/a

 

 

n/a

 

RSUs forfeited

 

n/a

 

 

n/a

 

 

 

 

 

 

 

 

 

 

$

 

Balance at March 31, 2026

 

 

2,249

 

 

$

7.06

 

 

8.68 years

 

$

279

 

 

 

684

 

 

$

3.00

 

Options vested and expected to vest at March 31, 2026

 

 

2,249

 

 

$

7.06

 

 

8.68 years

 

$

279

 

 

 

 

 

 

 

Options exercisable at March 31, 2026

 

 

635

 

 

$

16.66

 

 

7.21 years

 

$

141

 

 

 

 

 

 

 

Stock-based compensation expense for the period

 

$

373

 

 

 

 

 

 

 

 

 

 

$

242

 

 

 

 

Unrecognized stock-based compensation expense

 

$

3,476

 

 

 

 

 

 

 

 

 

 

$

1,681

 

 

 

 

Weighted average remaining recognition period

 

2.39 years

 

 

 

 

 

 

 

 

 

 

2.18 years

 

 

 

 

Schedule of Assumptions Used to Calculate Fair Value of Stock Options The assumptions used to calculate the Black-Scholes grant date fair value for such time-based awards were as follows:

 

 

Three Months Ended
March 31,

 

 

2026

 

 

2025

 

Expected life

 

 

 

 

6.18 years

 

Risk-free interest rates

 

 

 

 

 

4.15

%

Volatility

 

 

 

 

 

103.71

%

Dividend yield

 

 

 

 

 

0

%

Summary of Stock-based Compensation Expense

iMDx recorded stock-based compensation expense in the following categories on the accompanying consolidated statements of operations:

 

 

Three Months Ended
March 31,

 

 

2026

 

 

2025

 

 

(In thousands)

 

Cost of revenues

 

$

 

 

$

 

Research and development

 

 

159

 

 

 

195

 

Sales and marketing

 

 

58

 

 

 

38

 

General and administrative

 

 

398

 

 

 

240

 

Total

 

$

615

 

 

$

473